Literature DB >> 20945438

Reprogramming the pluripotent cell cycle: restoration of an abbreviated G1 phase in human induced pluripotent stem (iPS) cells.

Prachi N Ghule1, Ricardo Medina, Christopher J Lengner, Matthew Mandeville, Meng Qiao, Zbigniew Dominski, Jane B Lian, Janet L Stein, Andre J van Wijnen, Gary S Stein.   

Abstract

Induced pluripotent stem (iPS) cells derived from terminally differentiated human fibroblasts are reprogrammed to possess stem cell like properties. However, the extent to which iPS cells exhibit unique properties of the human embryonic stem (hES) cell cycle remains to be established. hES cells are characterized by an abbreviated G1 phase (∼ 2.5 h) and accelerated organization of subnuclear domains that mediate the assembly of regulatory machinery for histone gene expression [i.e., histone locus bodies (HLBs)]. We therefore examined cell cycle parameters of iPS cells in comparison to hES cells. Analysis of DNA synthesis [5-bromo-2'-deoxy-uridine (BrdU) incorporation], cell cycle distribution (FACS analysis and Ki67 staining) and subnuclear organization of HLBs [immunofluorescence microscopy and fluorescence in situ hybridization (FISH)] revealed that human iPS cells have a short G1 phase (∼ 2.5 h) and an abbreviated cell cycle (16-18 h). Furthermore, HLBs are formed and reorganized rapidly after mitosis (within 1.5-2 h). Thus, reprogrammed iPS cells have cell cycle kinetics and dynamic subnuclear organization of regulatory machinery that are principal properties of pluripotent hES cells. Our findings support the concept that the abbreviated cell cycle of hES and iPS cells is functionally linked to pluripotency.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20945438      PMCID: PMC3045197          DOI: 10.1002/jcp.22440

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  34 in total

1.  NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription.

Authors:  J Zhao; B K Kennedy; B D Lawrence; D A Barbie; A G Matera; J A Fletcher; E Harlow
Journal:  Genes Dev       Date:  2000-09-15       Impact factor: 11.361

2.  Identification of HiNF-P, a key activator of cell cycle-controlled histone H4 genes at the onset of S phase.

Authors:  Partha Mitra; Rong-Lin Xie; Ricardo Medina; Hayk Hovhannisyan; S Kaleem Zaidi; Yue Wei; J Wade Harper; Janet L Stein; André J van Wijnen; Gary S Stein
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

Review 3.  Naive and primed pluripotent states.

Authors:  Jennifer Nichols; Austin Smith
Journal:  Cell Stem Cell       Date:  2009-06-05       Impact factor: 24.633

4.  Expression of NPAT, a novel substrate of cyclin E-CDK2, promotes S-phase entry.

Authors:  J Zhao; B Dynlacht; T Imai; T Hori; E Harlow
Journal:  Genes Dev       Date:  1998-02-15       Impact factor: 11.361

5.  Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs.

Authors:  Jacob Hanna; Albert W Cheng; Krishanu Saha; Jongpil Kim; Christopher J Lengner; Frank Soldner; John P Cassady; Julien Muffat; Bryce W Carey; Rudolf Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-04       Impact factor: 11.205

6.  HiNF-P directly links the cyclin E/CDK2/p220NPAT pathway to histone H4 gene regulation at the G1/S phase cell cycle transition.

Authors:  Angela Miele; Corey D Braastad; William F Holmes; Partha Mitra; Ricardo Medina; Ronglin Xie; Sayyed K Zaidi; Xin Ye; Yue Wei; J Wade Harper; Andre J van Wijnen; Janet L Stein; Gary S Stein
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

7.  Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells.

Authors:  Matthias Stadtfeld; Effie Apostolou; Hidenori Akutsu; Atsushi Fukuda; Patricia Follett; Sridaran Natesan; Tomohiro Kono; Toshi Shioda; Konrad Hochedlinger
Journal:  Nature       Date:  2010-04-25       Impact factor: 49.962

8.  Human embryonic stem cells are pre-mitotically committed to self-renewal and acquire a lengthened G1 phase upon lineage programming.

Authors:  Klaus A Becker; Janet L Stein; Jane B Lian; Andre J van Wijnen; Gary S Stein
Journal:  J Cell Physiol       Date:  2010-01       Impact factor: 6.384

9.  Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures.

Authors:  Mark H Chin; Mike J Mason; Wei Xie; Stefano Volinia; Mike Singer; Cory Peterson; Gayane Ambartsumyan; Otaren Aimiuwu; Laura Richter; Jin Zhang; Ivan Khvorostov; Vanessa Ott; Michael Grunstein; Neta Lavon; Nissim Benvenisty; Carlo M Croce; Amander T Clark; Tim Baxter; April D Pyle; Mike A Teitell; Matteo Pelegrini; Kathrin Plath; William E Lowry
Journal:  Cell Stem Cell       Date:  2009-07-02       Impact factor: 24.633

10.  Cyclin D2 and the CDK substrate p220(NPAT) are required for self-renewal of human embryonic stem cells.

Authors:  Klaus A Becker; Prachi N Ghule; Jane B Lian; Janet L Stein; Andre J van Wijnen; Gary S Stein
Journal:  J Cell Physiol       Date:  2010-02       Impact factor: 6.384

View more
  44 in total

Review 1.  Targeted gene therapies: tools, applications, optimization.

Authors:  Olivier Humbert; Luther Davis; Nancy Maizels
Journal:  Crit Rev Biochem Mol Biol       Date:  2012 May-Jun       Impact factor: 8.250

2.  Human induced pluripotent cells resemble embryonic stem cells demonstrating enhanced levels of DNA repair and efficacy of nonhomologous end-joining.

Authors:  Jinshui Fan; Carine Robert; Yoon-Young Jang; Hua Liu; Saul Sharkis; Stephen Bruce Baylin; Feyruz Virgilia Rassool
Journal:  Mutat Res       Date:  2011-06-28       Impact factor: 2.433

Review 3.  The tumorigenicity of human embryonic and induced pluripotent stem cells.

Authors:  Uri Ben-David; Nissim Benvenisty
Journal:  Nat Rev Cancer       Date:  2011-03-10       Impact factor: 60.716

4.  cAMP and EPAC Signaling Functionally Replace OCT4 During Induced Pluripotent Stem Cell Reprogramming.

Authors:  Ashley L Fritz; Maroof M Adil; Sunnie R Mao; David V Schaffer
Journal:  Mol Ther       Date:  2015-02-10       Impact factor: 11.454

Review 5.  The cell cycle in stem cell proliferation, pluripotency and differentiation.

Authors:  Lijun Liu; Wojciech Michowski; Aleksandra Kolodziejczyk; Piotr Sicinski
Journal:  Nat Cell Biol       Date:  2019-09-02       Impact factor: 28.824

Review 6.  Mechanisms maintaining genomic integrity in embryonic stem cells and induced pluripotent stem cells.

Authors:  Elisia D Tichy
Journal:  Exp Biol Med (Maywood)       Date:  2011-07-18

7.  Epigenetic control of cell cycle-dependent histone gene expression is a principal component of the abbreviated pluripotent cell cycle.

Authors:  Ricardo Medina; Prachi N Ghule; Fernando Cruzat; A Rasim Barutcu; Martin Montecino; Janet L Stein; Andre J van Wijnen; Gary S Stein
Journal:  Mol Cell Biol       Date:  2012-07-23       Impact factor: 4.272

8.  Stabilization of mouse haploid embryonic stem cells with combined kinase and signal modulation.

Authors:  Haisen Li; Ao Guo; Zhenfei Xie; Wanzhi Tu; Jiali Yu; Huihan Wang; Jian Zhao; Cuiqing Zhong; Jiuhong Kang; Jinsong Li; Shichao Huang; Li Shen
Journal:  Sci Rep       Date:  2017-10-16       Impact factor: 4.379

9.  High Basal Levels of γH2AX in Human Induced Pluripotent Stem Cells Are Linked to Replication-Associated DNA Damage and Repair.

Authors:  Haritha Vallabhaneni; Patrick J Lynch; Guibin Chen; Kyeyoon Park; Yangtengyu Liu; Rachel Goehe; Barbara S Mallon; Manfred Boehm; Deborah A Hursh
Journal:  Stem Cells       Date:  2018-07-28       Impact factor: 6.277

10.  Cdk1 Controls Global Epigenetic Landscape in Embryonic Stem Cells.

Authors:  Wojciech Michowski; Joel M Chick; Chen Chu; Aleksandra Kolodziejczyk; Yichen Wang; Jan M Suski; Brian Abraham; Lars Anders; Daniel Day; Lukas M Dunkl; Mitchell Li Cheong Man; Tian Zhang; Phatthamon Laphanuwat; Nickolas A Bacon; Lijun Liu; Anne Fassl; Samanta Sharma; Tobias Otto; Emanuelle Jecrois; Richard Han; Katharine E Sweeney; Samuele Marro; Marius Wernig; Yan Geng; Alan Moses; Cheng Li; Steven P Gygi; Richard A Young; Piotr Sicinski
Journal:  Mol Cell       Date:  2020-04-01       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.